Article
The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation
2022-02-13
Abstract excerpt
<h4>Aims: </h4>: This study aimed to analyze associations between genetic variants and plasma concentrations along with clinical outcomes in dabigatran in patients with non-valvular atrial fibrillation (NVAF). <h4>Methods:</h4> We conducted a prospective study and enrolled NVAF patients treated with dabigatran in the real world. A total of 86 patients treated with 110 mg DE twice daily were recruited for this stud...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7341e4b9-4472-51c0-85e4-c7b81be5c2f8
- DOI
- 10.22541/au.164475230.08047039/v1
